Dental Hygiene Devices Market Insights, Deep Analysis of Key Vendor in the Industry 2022-2028

Prominently operated by Colgate-Palmolive Company, Glaxo Smith Kline plc, Johnson & Johnson, P&G, Unilever plc, and Dentsply Sirona, the dental hygiene devices landscape is currently witnessing dominance of toothbrush sales. In recent years, the dramatic growth of the E-commerce sector is translating into elevating online sales of dental hygiene devices, which is posing strong competition facing the retail pharmacy segment.

Toothbrush Records Highest Sale, Online Retail Firms up

A recent market research study by Future Market Insights provides exclusive insights on the current and prospective performance of global dental hygiene devices market, in terms of sales volume as well as revenue.

“The report categorizes dental hygiene devices landscape into the toothbrush, scalers, polishing devices, and others on the basis of product type. Toothbrush has been the top-selling product in global dental hygiene devices landscape, attributed to widespread availability, extensive selection range, broad price range, and frequent innovation,” explains a senior research analyst at FMI.

Currently, toothbrush sales account for almost 60% of the total market revenue, whereas the report indicates that dental scalers and dental polishing devices are gradually gaining ground. The study projects over 5% year over year revenue growth for the latter two in 2019 and ahead.

Retail pharmacies will remain the largest revenue generating channel of distribution in dental hygiene devices market. Whereas, online pharmacies are slated to present promising investment opportunities to dental hygiene devices manufacturers. The report projects that revenue generated through online retail would cross the US$ 1 billion mark in the next 3-4 years.

To remain ‘ahead’ of your competitors, request for a sample 

Key Players :

Colgate-Palmolive Company

The Procter & Gamble Company

Koninklijke Philips N.V.

Unilever plc.

Glaxosmithkline plc

Ultradent Products Inc.

Johnson & Johnson

3M Company

Dabur India Ltd.

Dentsply Sirona.

Key Dynamics Prompt at Rising Oral Care Concerns

The global dental hygiene devices market is low-value high-volume landscape, which remains the key factor that dampens investment. While baby boomers have been referred to as the primary consumers of dental hygiene devices, a growing percentage of juvenile and millennial people afflicted with one or more oral health problems points to the widening prospects of dental hygiene devices in coming years.

Increasing dental disease prevalence, coupled with the increasingly sophisticating infrastructure of dental care across developing regions, is predominantly responsible for improving the scope of dental hygiene devices penetration. Dental caries, periodontal conditions, and oral cancer mark some of the most significant concerns related to oral healthcare, among the population.

Asian Economies Create an Attractive Investment Pocket

The report sheds light on all the aspects related to worldwide demand for dental hygiene devices and offers insights on the growth prospects projected for global dental hygiene devices market through the next few years. The report forecasts steady yet moderate yearly revenue growth of 4.7% in 2019, and around 1/3rd of the total market value is poised to be accounted for by the Asia Pacific. North America and Western Europe are likely to hold a collective share of more than a third of the global market value.

APAC and Latin America are poised to remain highly lucrative regional markets for manufacturers of dental hygiene devices owing to consistently increasing demand for dental treatments in these regions.

Although the widening patient pool is driving the steady demand for dental hygiene devices, a sizeable population based in developing countries is still undiagnosed and untreated. FMI research points to the presence of several untapped opportunities in a massive untreated population and thereby highlights high attractiveness of emerging regional markets for dental hygiene devices manufacturers.

Besides frequent product innovations, key players in the global dental hygiene devices market maintain their strategic focus on the enhancement of distribution channel by strengthening existing marketing efforts across Asian markets, particularly in India, Singapore, and Malaysia.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8177

Toothpaste Innovations Account for a Trending Wave

The report suggests that strategic collaborations, new product launches, and geographical expansion remain the highlights of developmental strategies adopted by key companies operating in dental hygiene devices landscape. Electric/battery-operated toothbrush innovations continue to shape new launch strategies of a majority of companies, whereas most of the market leaders are focusing on introducing novel toothpaste ranges specific to various oral care demands.

GSK recently unveiled a range of Aquafresh Advance specifically for 9-12 years olds’ demographic, targeting enamel protection and cavity prevention. The company’s Consumer Healthcare arm also launched a new Sensodyne Rapid Relief range in the US. P&G also released a new toothpaste range recently, specifically for improved gum health. Dabur India Ltd. launched a modern variant of their flagship toothpaste range i.e. ayurvedic specialist toothpaste in gel format.For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/8177

Segmentation

The report offers a comprehensive taxonomy of dental hygiene devices market based on product type, distribution channels and region.

The product type segment of the dental hygiene devices market includes tooth brush, dental polishing devices, dental scalers and other dental devices. The distribution channel segment of the dental hygiene devices market includes hospital pharmacies, retail pharmacies, and online pharmacies. The dental hygiene devices market has been analyzed across regions of North America, Latin America, Europe, Asia Pacific and MEA.

Hydrocephalus Shunt Market : Notable Developments & Geographical Outlook 2022 to 2028

Future Market Insights foresees significant growth opportunities in hydrocephalus shunt market, considering the new-age development of smart shunt technology, while delivering advance diagnosis of cerebrospinal fluid (CSF), control, and communication, on the basis of sensors, telemetry, and feedback controls. Increasing focus on developing such smart shunt technology, is anticipated to prove favorable for the hydrocephalus shunt market—showcasing an otherwise sluggish landscape through the forecast period of 2018-2028, as per FMI’s analysis.

The research intelligence report offers a deep-dive view of the global hydrocephalus shunt market—predicted to expand at a rather sluggish rate of 2.3 percent, reaching a valuation of US$ 498.6 Mn in 2020.

To remain ‘ahead’ of your competitors, request for a sample 

“Stringent regulatory policies is a key factor severely impacting the growth of hydrocephalus shunt market. In addition, mechanical risks including leaks, migration, obstruction, and discontinuity and biological complications including infection, abscess, pseudocyst, heamotoma, and peritonitis associated with shunt implants, is also a key factor contributing to the market’s slow-moving growth. Other contributing factors could include high surgery costs and shortage of trained neurologist—specifically reported in countries like Australia, Canada, Ireland, U.K, and New”, explains a senior analyst from the Healthcare domain. The analyst further explains that shunt blockage and malfunction are two common complication associated with stunt implants—blockages occurring in nearly 31 percent patients. Moreover, such risks and complications often result in a number of hydrocephalus shunt revision surgeries, further creating a notable demand for hydrocephalus shunt.

Competitive Landscape

This section of the report features profiles of the key players operating in the hydrocephalus shunt market based on their market shares, differential strategies, product offerings, marketing approach, and company dashboard. Examples of some of the key players featured in this report include

Medtronic Plc.,

Braun Melsungen AG,

Integra LifeSciences Corporation,

Natus Medical Incorporated,

Tokibo Co., Ltd. (Sophysa SA),

Christoph Miethke GmbH & Co. KG, among others.

Many companies in the hydrocephalus shunt market are aiming on development of smart shunt technology and to gain FDA approvals. The manufacture are mainly focusing on acquisition and collaboration activities to expand their product portfolio in the hydrocephalus shunt market. Since 1999, Aesculap division of B. Braun Melsungen AG and Christoph Miethke GmbH & Co. KG have been working together to develop and sale hydrocephalus shunts.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-7756

FMI offers key insights on the global hydrocephalus shunt market

Hydrocephalus valves segment is expected to hold a massive value share of nearly 85 percent.

Within the Hydrocephalus valves type, adjustable pressure valves is likely to witness maximum adoption in hydrocephalus shunt surgeries.

Highest growth potential exists in North America, with an attractiveness index of 2.6 during the forecast period. Such adoption trend is expected to be followed in Western Europe—the second most lucrative market, showcasing interesting profit possibilities.

By age group, pediatrics and infants segment will report maximum adoption of hydrocephalus shunt.

Ventriculoperitoneal will remain the most preferred procedure, pushing maximum revenue in the global hydrocephalus shunt.

Key Market Influencers: Technological Advancements and Awareness Campaigns for Hydrocephalus

Considering the complexity of hydrocephalus shunting along with adjustments of cerebrospinal fluid draining, manufacturers of hydrocephalus shunts are increasingly introducing programmable and anti-siphon shunt valves—aimed at regulating drainage pressure and flow. The new technologies are indicated to eliminate the need for surgery revisions as a result of complications. The cerebrospinal fluid management technologies are likely to witness increased adoption in the coming years considering its utility in reducing siphon effect over cerebrospinal fluid drainage. Programmable pressure valves are gaining prominence versus fix pressure valves owing to its external features using specialized magnetic devices that helps in modifying opening pressure of valves.

Additionally, demand for hydrocephalus shunts is slated to increase given the increasing number of government and private initiatives to spread awareness vis-à-vis hydrocephalus. Hydrocephalus Association, for instance, and its focus to conduct more hydrocephalus awareness campaigns and programs, with increased investments in research initiatives targeted at improving cure and treatment avenues for Hydrocephalus. Through its campaign ‘Roadmap to a Cure’, the organization, by 2020 is expected to invest US$20 and drive more research and support associated with hydrocephalus.

In the highly consolidated hydrocephalus shunt market,

product and pricing power lies in the hand of top three players—reigning over nearly 84 percent of the total revenue share in the global hydrocephalus shunt market. Contributing nearly US$ 389 Million, the top three players include Medtronic Plc., Integra LifeSciences Corporation, and B. Braun Melsungen AG. Key forward market strategies include- viz. Efforts to gain regulatory approvals, geographic expansions in emerging economies, production capacity expansion, increased investments in R&D, and acquisitions to solidify global position in neurosurgery and regenerative technologies. Strategic collaborations in the form of mergers and acquisitions, is expected to bring significant growth opportunities for the three leading players, predicts FMI in its hydrocephalus shunt market report.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-7756

Segmentation

The report offers a comprehensive taxonomy of the hydrocephalus shunt market based on product type, procedure type, age group and region. By product type, the hydrocephalus shunt market is segmented into hydrocephalus valves and hydrocephalus catheters. Hydrocephalus valve segment is further sub-segmented into fix pressure valves and adjustable pressure valves. Hydrocephalus catheters segment is further sub-segmented into standard catheters and antimicrobial catheters.

By procedure type, the hydrocephalus shunt market is segmented into

ventriculoperitoneal

ventriculoatrial

lumboperitoneal

ventriculopleural.

By age group, the hydrocephalus shunt market is segmented into pediatric and adult segment.

The hydrocephalus shunt market has been analyzed across eight regions including

North America,

Latin America,

Europe,

Asia Pacific Excluding China & Japan,

China,

Japan, and MEA.

Gynaecological Examination Chairs Market 2022 Industry Research, Segmentation, Key Players Analysis and Forecast to 2028

With the growing income of people across the globe, they are willing to pay more for healthcare, the revenue being generated by hospitals is also increasing rapidly. Hospitals and various healthcare facilities are also increasing their spending to enhance the quality of services and their equipment. The proliferating healthcare expenditure is expected to positively impact the gynaecological examination chairs market.

As a result of the growing demand and expenditure of the consumers, companies are also gearing up in order to take leverage of the arising opportunities and to stay competent in the market. They are strengthening product portfolio by launching novel products with advanced features through product development and acquisitions and mergers. The companies are also concentrating on developing a strong distribution channel and supplier chain in order to expand their presence in the emerging and untapped markets. For instance, in May 2017, Oakworks Inc. announced the introduction of STUDIO, a table designing solution that provides clients with complete flexibility when designing products. Along this line in the same time, the company completed the collaboration with FAMED Medical Solutions. Due to collaboration the company introduce novel iNSPIRITMedical Solutions.

To remain ‘ahead’ of your competitors, request for a sample 

According to a report published by Future Market Insights (FMI), the global gynaecological examination chairs market is expected to witness a CAGR of 6.9% from 2018 to 2028. The market was worth US$ 408.4 Mn in 2017 and is projected to rise to a valuation of US$ 852.3 Mn by the end of 2028.

Advances in Technology to Have a Positive Impact on the Market

The healthcare industry around the globe is booming exponentially. Heavy investments are made in the healthcare industry, especially in the hospital and clinics sectors. The demand for technologically advanced products is increasing among practitioners and physicians for reducing operating and examination time. Adoption of technologically advanced chairs powered by foot switches and remote will be beneficial in adjusting the required height. These advance features provide efficiency in examination. Gynaecologists across the globe are adopting advanced gynaecological chairs that are compatible with video colposcopy device holders, organic waste containers and are made of antimicrobial materials in order to reduce the time and manpower required to manage all the adjustments.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-6750

Strict Regulations to Act as a Prime Roadblock in Market Growth

The companies in the market are facing strict regulatory policies in the development of new products for medical furniture, such as examination chairs and tables. The manufactured products should meet the standards of the U.S. Access Board Proposed Standards for Accessible Medical Diagnostic Equipment. Most of the companies are facing difficulties in bringing gynaecology examination chairs to the market without greater predictability and transparency from FDA. The products have to meet the standard of sterilization and environment protection regulation.

Parent Indicators Healthcare

Current expenditure on health, % of gross domestic product

Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)

Annual growth rate of current expenditure on health, per capita, in real terms

Out-of-pocket expenditure, % of current expenditure on health

Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)

Physicians, Density per 1000 population (head counts)

Nurses, Density per 1000 population (head counts)

Total hospital beds, per 1000 population

Curative (acute) care beds, per 1000 population

Medical technology, Magnetic Resonance Imaging units, total, per million population

Medical technology, Computed Tomography scanners, total, per million population

Market Taxonomy

The global gynaecological examination chairs market has been segmented into:

Product Type

Non-electric gynaecological Examination Chairs

Electric gynaecological Examination Chairs

Price Range

Premium

Medium

Low-price

End User

Hospitals

Obstetrics & Gynaecology Clinics

Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-6750

Region

North America

Western Europe

Eastern Europe

Latin America

Asia Pacific Excl. China & Japan

(APECJ)

China

Japan

Middle East and Africa

Instrument Cleaners and Detergents Market 2022 Key Players, End User, Demand and Consumption by 2031

Increase in incidence of hospital-acquired infections is enabling growth in the instrument cleaners and detergents market, which is expected to reach US$ 2.02 Bn in 2021. The market is projected to register growth at a positive pace between 2021 and 2031, driven by the increasing occurrence of hospital-acquired infections (HAIs).

Hospital-acquired infections have emerged as a key health concern, influencing patient recovery that has a significant effect on mortality recorded worldwide. In addition, the increase in the occurrence of surgical site infections is expected to drive the market.

Hospitals utilize various medical instruments during the course of treatment and diagnosis of the patients. These medical instruments ought to be disinfected and cleaned on daily basis which requires the detergents and cleaners.

Apart from this, rising cases of chronic diseases, growing overall population, and improving medical care awareness among general people are some of the primary reasons driving the instrument cleaners and detergents market.

To remain ‘ahead’ of your competitors, request for a sample

Spurred by favorable trends, some of the leading pharmaceutical companies are focusing on expanding their product scope across various distribution channels. Currently, the market can be broadly categorized into cleaners and detergents in terms of products. Of these, detergents are forecast to account for over 73% of sales in the market by 2031.

Rising demand from hospitals and various other healthcare institutions will remain a chief growth driver. Amid COVID-19 outbreak, focus on sanitization is at all-time high. This has caused the sales of instrument cleaners and detergents to soar as well.

Key Takeaways from Instrument Cleaners and Detergents Market Study

Instrument cleaners and detergents market will register 4.1% CAGR between 2021 and 2031, thanks to higher focus on curbing the incidence of infection in healthcare institutions

Demand from hospitals will continue rising. Hospitals are likely to emerge as dominant end user and reach a market value of US$ 1.1 Bn by 2031

The U.S. is the most lucrative market in the global instrument cleaners and detergents market and is expected to grow at a CAGR of 4.4% between 2021 and 2031

After a period of positive growth, the demand will drop slightly in the U.K. In 2021, the U.K. market is expected to register 3.7% y-o-y growth

China and Japan are likely to dominate sales registered in East Asia

“Expansion of the healthcare sector globally, increasing cases of hospital acquired infections, rise in the prevalence of surgical site infections, and increasing investments by governments to improve healthcare infrastructure will present a conducive environment for increasing sales of instrument cleaners and detergents,” says the FMI Analyst

Key Participant Insights

The instrument cleaners and detergents market is set to expand in the forecast period, as a result of rising prevalence of various infectious diseases, and growing investment in R&D. Some of the leading companies are actively engaging into acquisitions and expansion in order to enhance their product portfolio and outreach.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-10828

Key Market Players Covered By FMI Include:

Metrex Research

LLC , Ruhof Corporation

Case Medical, Inc.

Certol International LLC

Dr. Weigert, Biotrol

ORO Clean Chemie AG

Medalkan

STERIS Plc

Getinge Group

Ecolab Inc.

3M Co.

Cantel Medical Corporation

EQT (Schülke & Mayr GmbH)

Fortive Corporation (Advanced Sterilization Products)

Medline Industries, Inc.

Who is Winning?

Some of the leading players operating in the market are concentrating on rising acquisitions at territorial levels. The pattern is mainly seen across Europe and North America. Acquisitions offer organizations the scope to expand portfolio. It is therefore one of the key strategies adopted by the market players to strengthen their footprint. For instance:

In, January 2021, STERIS Plc and Cantel Medical Corp  announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary.  Cantel is a global provider of infection-prevention products and services, primarily to endoscopy and dental Customers.

In December 2020, CANTEL MEDICAL CORP. and Censis Technologies announced a new long-term partnership to combine Cantel’s leading infection-prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis.

Instrument Cleaners and Detergents Market by Category

By Product Type:

CleanersLiquid Solutions

Foam-based Cleaners

Gel-based Cleaners

DetergentsEnzymatic Detergents

Neutral Detergents

Acidic Detergents

Alkaline Detergents

By Process Type:

Presoak

Manual cleaning

Automatic Cleaning

Disinfection

By Instrument Type:

Surgical instruments

Endoscopes

Ultrasound

Dental Instruments

Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-10828

By End User:

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Specialty Clinics

Others

By Region:

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa (MEA)

Gastric Electric Stimulators Market 2022 Key Players, SWOT Analysis, Key Indicators and Forecast to 2026

The worldwide uptake of gastric electric stimulators is anticipated to witness hefty demand in 2019, representing a rigorous 6.6% y-o-y growth, while reaching a valuation of approx. US$ 188.4 Million in 2026. As per Future Market Insights (FMI) report on gastric electric stimulators market for the forecast period 2018–2026, gastric electric stimulators’ demand is anticipated to be accelerated by a host of pacesetters.

The FMI report on gastric electric stimulators market opines that sales of gastric electric stimulators are likely to witness sheer proliferation in coming time, on the back of burgeoning minimally invasive procedures, surging reported cases of gastroparesis, and encouraging reimbursement schemes. Growing pervasiveness of gastroparesis has been identified as the primary demand generating factor making gastric electric stimulators highly preferred treatment substitute for such arduous diseases.

“Enterra system, a critical medical device which is highly used to treat Gastroparesis has received FDA approval as a humanitarian use device, on the back of its potential to treat or diagnose a disease or condition affecting approx. 4000 individuals annually in the United States. Though conditionally, the American College of Gastroenterology (ACG) also recommends adoption of gastric electric stimulators for individuals with chronic, stubborn nausea and vomiting caused by Gastroparesis. The gastric electric stimulators, like Enterra, is a battery-based gastric neurostimulator, which is usually rooted under the skin in lower abdomen part of the body”, Senior Analyst, FMI.

“To remain ‘ahead’ of your competitors, request for a sample”

As per the FMI report on gastric electric stimulators market, considering the rareness of Gastroparesis in tandem with the widespread occurrence of gastric-related issues, investments in R&D and clinical studies have considerably increased in the recent past. Moreover, the growing adoption of gastric electric stimulators as an effective substitute to gastrectomy in patients with end-stage gastric dysfunction, is projected to accelerate the demand for gastric electric stimulators considerably by the end of 2026.

High-Frequency Product Type Gaining Colossal Traction

According to the FMI report, high-frequency variant of gastric electric stimulators are witnessing mammoth traction as being one of the most compelling product type, in comparison to the low-frequency variant of gastric electric stimulators. The FMI gastric electric stimulators market report opines that high-frequency variant of gastric electric stimulators aren’t just minimally invasive and extremely patient-friendly in terms of insertion, but also encompass comparatively longer battery life than the low-frequency variant of gastric electric stimulators. Additionally, as per FMI analysis, with over 75% gastric stimulators market share, high-frequency variant of gastric electric stimulators is likely to ameliorate the Gastroparetic treatment landscape.

Though, gastric electrical stimulation makes the most viable treatment option for chronic drug-refractory nausea and vomiting peripheral to Gastroparesis of idiopathic or diabetic etiology, Enterra Therapy associated risks remain exceptionally high, thereby hampering the adoption of gastric electric stimulators.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8992

Gastric Electric Stimulators Market- Competitive Dashboard

Some of the key manufacturing companies operating in the gastric electric stimulators market space include:

ReShape Lifesciences, Inc.,

IntraPace Inc.,

Changzhou Ruishen Medical Equipment Co., Ltd,

Medtronic Plc., and others.

The key players have been featured in the report based on multiple factors, including differential strategies, advertising approaches, product offerings, geographical presence, and key focus areas. The leading manufacturers operating in the global gastric electric stimulators market will continue to focus on commercializing technologically advanced products with enhanced functionality and reliability.

North America Gastric Electric Stimulators Market Remains Lucrative FMI gastric electric stimulators report opines that North America is likely to retain its dominance in the gastric electric stimulators market between 2018 and 2026. According to the FMI report on gastric electric stimulators market, growing investments in medical studies and R&D activities, continuing technical advancements and innovations, coupled with the presence of several leading market players, are other key factors paving way for lucrative opportunities in across North America gastric electric stimulators market. According to gastric electric stimulators market report, the worldwide gastric electric stimulators market will continue to remain highly consolidated with market Mughals contributing approx. 5o% revenue share to global gastric electric stimulators market, owing to their superior product offering and extensive demographic presence. Further, to capitalize on the growing demand for gastric electric stimulators, leading market players are poised to indulge into collaborations and acquisitions of local players, to reinforce their market presence.

Key Segment Based on Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa (MEA)

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8992

Based on Product Type

high frequency gastric electric stimulators devices

low frequency gastric electric stimulators devices

Based on Indication

refractory nausea

gastroparesis

obesity

Continuous Peripheral Nerve Block Catheter Market Research Report 2022 – Global Forecast till 2027

Future Market Insights has delivered key insights and presented a revised forecast analysis on continuous peripheral nerve block catheters market in its new research study titled “Continuous Peripheral Nerve Block Catheter Market: Global Industry Analysis (2012-2016) and Forecast (2017-2027)”. Continuous peripheral nerve block catheter are increasingly being used for pain management in patients undergoing upper/lower extremity surgeries and patients suffering from trauma, owing to their advantages, such as meticulous precision and low-price. Continuous peripheral nerve block catheter are emerging as a credible alternative to opioids for pain management as ill-effects associated with opioids are very severe such as addiction to opioids

Global Continuous Peripheral Nerve Block Catheter Market: Forecast Highlights

The global continuous peripheral nerve block catheter market is anticipated to record a CAGR of 6.1% and the market is estimated to reach a value of US$ 742.7 Mn in 2027 from a valuation of around US$ 411 Mn in 2017.

To remain ‘ahead’ of your competitors, request for a sample

Global Continuous Peripheral Nerve Block Catheter Market: Segmental Analysis

The market is segmented based on product type, insertion technique, indication, end users and regions. On the basis of product type, the market has been segmented into stimulating catheter system, non-stimulating catheter systems and over-the-needle catheter systems. Non-stimulating catheter systems segment dominated the global continuous peripheral nerve block catheter market in terms of value and volume in 2017. This segment is expected to continue its dominating streak throughout the forecast period.

On the basis of insertion technique, the continuous peripheral nerve block catheter market has been segmented into nerve stimulation and ultrasound based insertion technique. Continuous peripheral nerve block catheter that uses ultrasound based insertion technique is expected to witness higher demand than devices that use nerve stimulation technique for catheter insertion. The ultrasound based insertion technique segment is projected to grow at a higher rate during the forecast period. However, the nerve stimulation based insertion technique segment is expected to show a higher market valuation.

On the basis of indication, the continuous peripheral nerve block catheter market has been segmented into trauma cases, upper extremity surgeries, lower extremity surgeries, pain management and other indications. Amongst these aforementioned segments, lower extremity surgeries segment is expected to witness higher revenue growth as compared to other segments over the forecast period and this segment is expected to show higher value CAGR throughout the period of assessment.

Key end-use sectors that generate the bulk of demand for continuous peripheral nerve block catheter can be broadly categorised into hospitals and ambulatory surgical centres. Among these, hospitals account for the largest revenue share of the market, owing to increasing number of hospitalisations for upper/lower extremity procedures carried out in hospitals. The hospital segment is a highly lucrative segment from an investment standpoint.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1307

FMI’s report has segmented the global continuous peripheral nerve block catheter market on the basis of region into North America, Western Europe, Eastern Europe, Latin America, Asia Pacific Excluding Japan (APEJ), Middle East & Africa and Japan. This report assesses trends driving each market segment and offers analysis and insights about the potential of continuous peripheral nerve block catheter in specific regions. The North America region is the leading region in terms of global revenue share, followed by Western Europe and Japan. North America is estimated to dominate the continuous peripheral nerve block catheter market with maximum value share of the overall market by end of 2017. North America continuous peripheral nerve block catheter market increase at a CAGR of 6.5% through 2027. Presence of key regional players, strong distribution network, and developed healthcare infrastructure are the key factors driving the growth of the market in North America.

Global Continuous Peripheral Nerve Block Catheter Market: Competitive Assessment

Some key players in the global continuous peripheral nerve block catheter market identified include:

B. Braun Melsungen AG,

Teleflex Incorporated,

Halyard Health, Inc.,

Epimed International Inc.

Pajunk GmbH.

Market Segmentation

By Product Type

Stimulating Catheter

Open Tip Catheter Stimulating Catheter

Closed Tip Catheter Stimulating Catheter

Non-Stimulating Catheter

Open Tip Catheter Non-Stimulating Catheter

Closed Tip Catheter Non-Stimulating Catheter

Over-The-Needle Catheter

By Insertion Technique

Nerve Stimulation Based Insertion

Ultrasound Based Insertion

By Indication

Trauma Cases

Upper Extremity Surgeries

Lower extremity Surgeries

Pain Management

Other Indications

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1307

By End User

Hospitals

Ambulatory Surgical Centers

By Region

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific Excluding Japan

Japan

Middle East & Africa

Radiopharmaceuticals Market 2022 | Present Scenario and Growth Prospects 2031

As per Future Market Insights (FMI), driven by rising cases of cancer and cardiovascular diseases, radiopharmaceutical market registered steady year-on-year growth at 4.90% CAGR in 2021.

Increasing development of radioisotopes to curb the cases of cancer have propelled the market demand, topping a valuation of US$ 6,107.2 Mn in 2021. Rising cases of prostate and breast cancer, especially in developed countries including the U.S., the U.K., and Germany, have increased the application of radiopharmaceuticals.

Government initiatives and research activities undertaken to develop advanced radioisotopes for the treatment of cancer and to develop novel therapeutics will boost the demand. Also, introduction of novel technologies such as Positron Emission Technology and others in nuclear imaging systems will bolster growth.

However, due to the global shutdown witnessed in the FQ-20 in response to the COVID-19 outbreak, growth declined considerably. Suspended production of radioisotopes and disruption in the research activities delayed the deployment of projects in the healthcare sector.

Although, with increasing development activities and increasing commercialization of radiopharmaceuticals by industry giants have picked up the pace for the growth of market. Alongside this, increasing cases of cancer will accelerate the development of nuclear medicines in the field of radiopharmaceuticals.

To remain ‘ahead’ of your competitors, request for a sample

Increasing preference of non-invasive medical therapies and production of radioisotopes for the treatment is another factor that will stabilize the growth of radiopharmaceuticals market. Based on this, FMI projects the market is poised to expand at over 4.66% CAGR during the forecast period of 2021 and 2031.

Prominent Players

Siemens AG

Positron Corporation

Novartis (Advanced Accelerator Applications)

Curium

GE Healthcare

Lantheus Holdings Inc.

Sotera Health LLC

Bayer AG

Eckert & Ziegler

Key Takeaways from FMI’s Radiopharmaceuticals Market Study

In terms of application, oncology will contribute over 50% of global market share owing to the rising prevalence of cancer across the globe.

Cyclotrons are expected to be the primary source of radiopharmaceuticals, accounting for maximum market share

Based on radioisotope type, technetium-99 will remain highly preferred radioisotope in the global radiopharmaceutical market

The U.S. will retain its global dominance backed by the high cancer and cardiovascular cases rising in the country

India will emerge as lucrative market owing to the favorable government initiatives promoting the radiopharmaceuticals market

Germany and the U.K. are spearheading the growth of Europe market, which is projected to grow at over 4.9% CAGR

“Increasing research and development initiatives aimed at the production of advanced radioisotopes and novel technologies will improve growth prospects for the leading players in the radiopharmaceuticals market,” says the FMI analyst.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1992

Competitive Landscape

Leading radiopharmaceuticals market players are focusing on expanding their customer base through strategic mergers and acquisition. Increasing research and development activities to develop advanced radioisotopes for the cancer treatment is another core strategy adopted by leading players.

Top 5 players including Siemens AG, GE Healthcare, Curium, Lantheus Holdings Inc., and Eckert & Ziegler are dominating the global radiopharmaceuticals market, contributing over 90% of revenue share.

In March 2021, Novartis announced the commercialization and obtained the rights to develop the therapeutic applications of Fibroblast Activation Protein (FAP) targeting agents including FAPI-46 and FAPI-74, through an assignment agreement with iTheranostics, Inc., an affiliate of SOFIE Biosciences, Inc.

Along with it the company announced the production and commercialization of new nuclear medicine, 18F sodium fluoride radiopharmaceutical in France.

In November 2020, Blue Earth Diagnostics, a leading molecular imaging diagnostic company, unveiled that their manufacturing company, Nucleis has manufactured and shipped their first doses of rhPSMA-7.3 (18F), an investigational Prostate-Specific Membrane Antigen (PSMA)-targeted radiohybrid PET imaging agent, for patients with prostate cancer.

Another industry giant, Jubilant Pharma Limited Company, in 2019, announced the integration of its radiopharmaceutical drug development and manufacturing business with its radio-pharmacy business into a global radiopharmaceutical brand, Jubilant Radiopharma.

Radiopharmaceuticals Market by Category

By Radioisotope Type:

Technetium-99

Fluorine-18

Iodine-131

Leutetium-177

Yttrium-90

Gallium-68

Gallium-67

Rubidium-82

Iodine-123

Iodine-125

Indium-111

Others

By Application:

Oncology

Cardiology

Gastroenterology

Neuroendocrinology

Neurology

Nephrology

Others

By Source:

Cyclotrons

Nuclear Reactors

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/1992

By End-User:

Hospitals

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Cancer Research Institute

By Region:

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific excluding Japan

Japan

Middle East & Africa (MEA)

Digital Wound Measurement Devices Market 2022 Development Status, Competition Analysis, Type and Application 2030

Wound care measurement has been acquiring immense significance in recent years. Growing incidences of traumatic injuries due to accidents and prevalence of chronic diseases such as diabetes mellitus are primary growth stimulants. Healthcare industries worldwide are adopting technologically enhanced wound management systems to provide quality care solutions to patients. As a result, digital wound measurement devices market is gaining steady ground.

Biosensors are being extensively incorporated as they are highly effective in providing critical data regarding bacterial colonization, oxygen, glucose and pH levels at the wound site, enabling doctors to diagnose and treat wounds accordingly. Several universities and institutions are augmenting their research capabilities to conduct further studies on biosensor-enabled devices.

Digital Wound Measurement Devices Market- Key Takeaways

A CAGR of 4.5% is projected for the forecast period ranging from 2020-2030

Rising smartphone and IoT device ownership is deepening telehealth penetration, providing traction to the market

Diabetic ulcers to account for the lion’s share owing to increasing prevalence of diabetes mellitus

North America to lay suzerainty over the global market, capturing over 40% market share

New product launches and collaborations constitute primary market expansion strategies of prominent vendors

To remain ‘ahead’ of your competitors, request for a sample 

COVID-19 Impact Analysis The wound care market has been impacted by the coronavirus pandemic, and is anticipated to experience a moderate slowdown in growth through 2021, attributed to a decline in surgical procedures. However, the chronic wound patient pool will continue requiring treatment, ushering in a consistent revenue stream for chronic wound devices. Practitioners are exploring opportunities to incorporate digital wound measurement devices to treat COVID-19 patients, primarily to provide relief from lung inflammation by checking and curtailing the secretion of interleukin-6, a pro-inflammatory cytokine. Demand for homecare wound measurement devices has spiked, attributed to increase in home visit frequencies across countries for patients suffering from chronic conditions. All these factors are expected to have a considerable influence on the market’s growth trajectory in the short-term forecast period.“Prominent vendors are looking to capture emerging markets across East & South Asia due to the presence of a large diabetic population base, opening up lucrative revenue generation opportunities during the forecast period,” says the FMI analyst.

Digital Wound Measurement Devices Market- Competitive Landscape

Prominent players within the digital wound measurement devices landscape include:

Perceptive Solutions Inc.

ARANZ Medical

Smith & Nephew plc

WoundVision Inc.

WoundMatrix Inc.

KCI

Parable Health

Hitachi Healthcare Americas

3M Company

WoundRight Technologies.

In 2017, WoundMatrix Inc., inked a decade long partnership with the Kent Community Health NHS Foundation Trust (KCHFT) to provide telemedicine and wound care programs aimed at improving healthcare services across the United Kingdom, including wound care and management.

In 2019, 3M successfully acquired Acelity Inc. with the objective of expanding its presence in the advanced and surgical wound care segment.

In June 2020, Perceptive Solutions, Inc. unveiled its new WoundZoom Wound Centric EMR System and 3D wound-imaging software solution. This software is an integrated wound management solution, comprising a wound-centric EMR system, 3D-imaging hardware and remote patient monitoring.

In July 2020, ARANZ Medical released the Silhouette version 4.9 which includes an improved range of data analysis features, such as a percentage area reduction figure, enabling clinicians to determine the effectiveness of wound healing.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-717

Enquiry before Buying

Is the digital wound measurement devices market research conducted by Future Market Insights?

Yes, the digital wound measurement devices market report has been compiled by expert analysts of Future Market Insights through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to the research analyst

What research methodology is followed by FMI?FMI follows a methodology that encompasses the demand side assessment of the market, and triangulates the same through a supply side analysis. This methodology is based on use of standard market structure, methods and definitions.

Who are the respondents for primary research?FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. For a full list of primary respondents, please reach out to us.

What are the sources of secondary research?FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Is a sample of this report available for evaluation?

Yes, you can request a sample and it will be sent to you through an email.

How can I buy this report?

FMI provides a secure online payment system to buy report seamlessly. You can buy the report securely and safely.

More Insights on the Digital Wound Management Devices Market

A recent market study published by FMI on the digital wound measurement devices market includes the global industry analysis of 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. The report is segmented on the basis of wound type (diabetic ulcers, chronic wounds, burns, incisional and traumatic), end-user (hospitals & clinics) and region (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Key Segments

Wound Type

Diabetic Ulcer

Chronic Wounds

Burns

Incisional

Traumatic

End User

Hospitals

Clinics

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-717

Region

North America (U.S & Canada)

Latin America (Brazil, Mexico, Argentina & Rest of Latin America)

Europe (Germany, Italy, France, U.K., Spain, BENELUX, Russia & Rest of Europe)

Middle East & Africa (GCC, Turkey, Northern Africa, Southern Africa & Rest of MEA)

East Asia (China, Japan & South Korea)

South Asia (India, Thailand, Indonesia, Malaysia & Rest of South Asia)

Oceania (Australia & New Zealand)

Dental X-ray Systems Market 2022 | Scope of Current and Future Industry 2026

Increasing incidences of acute diseases like cancer has created a robust demand for effective diagnostics and treatment for the early detection of this disease and increase the probability of survival. As a result, dental X-ray systems have witnessed a rapid rise in their demand, on the back of their qualification as a promising diagnostics and treatment procedure. In addition to this, the dental X-ray systems significantly reduce the radiation dose among the patients, which strengthens the trust of the medical practitioners in the equipment and boosts the growth of the dental X-ray systems market.

Rising geriatric population and their edentulous issues directly open lucrative opportunities for the dental X-ray systems market. Moreover, healthcare facilities utilized by the elderly population are subsidized by the government, which in turn, has boosted the usage of dental X-ray systems. According to a report published by Future Market Insights (FMI) opines that the global dental X-ray systems market will grow at a striking CAGR of over 6% by the end of 2026.

With the increasing comfort provided by the portable intraoral X-ray systems, the traditionally used floor mounted dental X-ray systems are gradually becoming obsolete. When weighted on the basis of cost, dental X-ray systems provides far better affordability to the dental clinics and hospitals as compared to the cone-beam computed tomography (CBCT) systems, which is why the sales prospects of the former are better.

To remain ‘ahead’ of your competitors, request for a sample

Challenges Pertaining to the Dental X-ray Systems Market: Reduction in Reimbursement

A notable reduction in the primary healthcare facilities for many diseases including oral health will affect the capacity and the resources adversely. Newly formed legislation will enforce reduced reimbursement regulations on the MPFS (Medicare Physician FEE Schedule) and HOPPS (Hospital Outpatient Prospective Payment System), which is expected to cause a drop in the growth of the dental X-ray systems market.

Technological Advancements to Lend Ample Growth Opportunities to the Dental X-ray Systems Market

Innovations and advancements brought about in the medical imaging vicinity and especially, dental X-ray systems have intensified the growth prospects of the dental X-ray systems market. Owing to the progress made by the healthcare industry, there has been a consistent need for the precise diagnosis of the diseases, which has been fulfilled by the dental X-ray systems. Given the multifold applications of these systems, the global dental X-ray systems market is projected to grow exponentially.

North America to Maintain a Strong Hold on the Global Dental X-ray Systems Market

The study on dental X-ray systems market provides a detailed analysis on the basis of several factors affecting the market growth. The key geographies assessed in this study include China, APEC, Europe, Latin America, North America, and Middle East and Africa (MEA). Depending on the market size, North America leads the dental X-ray systems market, attributed to the advanced healthcare facilities and excellent spending capacity. As a subsequence, the regional dental X-ray systems market is expected to bear positive results for the global dental X-ray systems market.

Following the footsteps of North America, Europe is the second most dominating region influencing the growth of the dental X-ray systems market. In addition to this, Asia Pacific is equally estimated to contribute to the growing market size during 2018 – 2026.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8960

Collaboration and Mergers to Trigger the Growth of the Dental X-ray Systems Market

The report on the dental X-ray systems market includes a comprehensive analysis of the companies devising innovative solutions in the market. The leading players incorporated in the report are

FONA

J. MORITA CORP.

Danaher Corporation

PLANMECA OY

Prexion Corporation

Carestream Dental

LLC

Owandy Radiology

Vatech Co. Ltd.

The Yoshida Dental Mfg. Co. Ltd.

Dentsply Sirona

LED Medical Diagnostics Inc.

Cefla S.C.

Air Techniques, Inc.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8960

Key Segment

Based on the product type

Cephalometric Projections Systems

Portable Intraoral X-ray Systems

Panoramic X-ray Systems

Intraoral X-ray Systems Mounted on the Floor

Based on the geographies

North America

Europe

Latin America

Middle East & Africa (MEA)

China

Over-the-Counter Pain Medication Market 2022 Outlook, Current and Future Industry Landscape Analysis 2028

The OTC (over-the-counter) pain medication market surpassed US$ 18 billion in 2018, with growth influenced by changing perceptions on generic pharmaceutical drugs, according to a recent study published by Future Market Insights (FMI). The study opines that market revenue will rev up at an improved rate of 3.7% to exceed US$ 19.3 billion in 2019. FMI analyzes various aspects of market growth influencing the OTC pain medication market.

Many consumers are making a shift to generic drugs to reduce total spending on non-prescription or OTC pain medication. Various governing bodies, such as the United States Food and Drug Administration (FDA), have implemented stringent regulations and labeling rules to ensure the safety and effectiveness of OTC pain medications. Leading players in the OTC pain medication market are collaborating with generic drug-makers to capitalize on the trend of consumer inclination towards generic versions of branded OTC pain medications, finds FMI.

The FMI study features valuable and actionable insights obtained through thorough research on OTC pain medication market. Some of the insights mentioned in the study are,

Growing geriatric population and prevalence of chronic pain-related disorders among the elderly population is bolstering sales of OTC pain medications.

Over 20% of the adult population of the world is already suffering from pain-related disorders and new cased of pain-related problems are reported by over 10% of the global population, which is increasing significantly every years. This is providing an impetus to growth of the OTC pain medication market.

Increasing awareness about the side effects of pain killers, such as stomach ulcers and gastrointestinal problems, may hamper the OTC pain medication market growth.

To remain ‘ahead’ of your competitors, request for a sample 

Developed countries will dominate the OTC pain medications market with more than half the revenue share of the market. However, developing countries in Southeast Asia will witness fastest growth in the OTC pain medication market with rapidly developing pharmaceuticals and healthcare sector in the region.

Acetaminophen Drugs Hold Majority Share in OTC Pain Medication Market

The FMI study thoroughly assesses growth of the OTC pain medication market based on various drug classes, such as Nonsteroidal anti-inflammatory drugs (NSAIDS), acetaminophen, and local anesthetics. The study finds that acetaminophens are among the most commonly purchased OTC pain medication, and this drug class holds 45% share in the revenues of OTC pain medication market. As acetaminophen is considered as a safer pain medication than other pain relievers, its demand will continue to remain high in the upcoming years, opines the FMI study.

The Consumer Healthcare Products Association (CHPA), an American trade association, recently published a study on the misuse of acetaminophen-based OTC combination products. The study found that a 28 percent decline was recorded in therapeutic misuse exposures involving acetaminophen-containing OTC combination products. The incidents of acetaminophen misuse decreased from 8,753 to 6,278 between 2007 and 2016, which is a substantial evidence for the safety and effectiveness of acetaminophen-containing OTC pain medications.

Thereby, the FMI study opines that the acetaminophen drugs will maintain a maximum share of over US$ 8.7 billion in the OTC pain medication market through 2019, and the trend will continue to persist in the coming future.

Prominent Players:

Pfizer, Inc.

Johnson & Johnson Services, Inc.

Bayer AG

Sanofi S.A.

GlaxoSmithKline plc.

Bristol-Myers Squibb and Company

Teva Pharmaceutical Industries Ltd

Mylan N.V.

Merck & Co

Cardinal Health Inc.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8947

Governments take Initiatives to Spread Awareness about Safe Use of OTC Pain Medications

Despite the increasing reliance on OTC pain medications, a large consumer group is still skeptical about their effectiveness and positive impacts on health. In order to help consumers to avoid incorrect use of OTC pain medications, many governing bodies including FDA have developed guidelines and tips for patients for choosing appropriate OTC pain medications. Consumers are becoming conscious about the drug fact labeling (DFL) requirements and other regulations vis-à-vis OTC pain medications, which is influencing major dynamics of the OTC pain medication market, projects the FMI study.

The study provides a futuristic overview of the OTC pain medication market with important information about growth prospects of the market during the forecast period 2018-2028. The study predicts that the OTC pain medication market will witness healthy growth at a healthy 4.5% value CAGR to reach US$ 13 billion by the end of the assessment period.

Additional Questions Answered

Additional questions addressed in this over-the-counter pain medication market report are-

What is the revenue potential of the over-the-counter pain medication market across North America and Europe?

Who are the key players and what are their product portfolios in the over-the-counter pain medication market?

What are the major challenges impacting the growth of the over-the-counter pain medication market?

How is the involvement from key regulatory bodies shaping the growth of the over-the-counter pain medication market?

Key Segment

Based on drug class

non-steroidal anti-inflammatory drugs (NSAIDs)

local anaesthetics

acetaminophen

Based on route of administration

oral

tropical

others

Based on dosage from

tablets

capsules

creams

gels

others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8947

Based on distribution channels

hospital pharmacies

drug stores

retail stores

e-commerce

others